Four top executives with West Chester, PA-based Synthes Inc. were indicted by the US Attorney for the Eastern District of Pennsylvania on charges that the company improperly engaged in off-label ...
EAST GOSHEN – U.S. regulators warned Swiss medical device maker Synthes Inc. about violations at its Brandywine plant on Goshen Parkway and said the company may have to pay a fine if it fails to fix ...
Hansjorg Wyss made the comments in a letter to be read out at an event in 2007 where Professor Webb was being honoured for his surgical endeavours.
The sentencing of three of the four ex-directors of medical device manufacturer Synthes to terms ranging from five to nine months over the unauthorized use of bone cement in spinal surgery clinical ...
Medical devices firm Synthes is well positioned to pursue its strategy of global expansion after buying its patents from an independent research foundation. The Solothurn-based firm recently paid SFr1 ...
PHILADELPHIA -- A Swiss company with major operations in West Chester, Pa., illegally tested its bone cement on about 200 people, three of whom died, according to a 52-count indictment issued Tuesday, ...
Synthes, Inc. announced that it has acquired The Anspach Effort, Inc., a global company in the high-speed surgical power tools market. Anspach, founded in 1978 by William E. Anspach, MD, focuses on ...
TRENTON, N.J. — Healthcare giant Johnson & Johnson said that it will complete its $19.7 billion purchase of Synthes today — a deal J&J hopes will give it a dominant position in the growing orthopedic ...
The dual-use robotics and standalone navigation platform will become part of the VELYS™ Enabling Technologies Portfolio and integrate with existing J&J MedTech Spine products PALM BEACH GARDENS, Fla., ...
DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, today announced the Europe, Middle East and Africa launch of the ATTUNE Revision Knee System, to complement the ATTUNE Primary ...
TRENTON, N.J. (AP) -- Healthcare giant Johnson & Johnson said Tuesday that it will complete its $19.7 billion purchase of Synthes on Thursday — a deal J&J hopes will give it a dominant position in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results